Table S1.

Median survival of intracranial primary glioma-bearing mice after treatment with NPs/pTRAIL-hADSCs, NPs/pCDNA-hADSCs, hADSCs, or PBS solution (n = 7)

GroupMS, dP value vs.
NPs/pTRAIL-hADSCs
Repetitive injectionSingle injectionNPs/pCDNA-hADSCshADSCsPBS solution
NPs/pTRAIL-hADSCs
 Repetitive injection45
 Single injection270.0254
NPs/pCDNA-hADSCs200.00230.0146
hADSCs220.00250.00690.9195
PBS solution200.00180.00470.68010.6056
  • MS, median survival.